Ristow, Oliver http://orcid.org/0000-0002-3911-262X
Hofele, Christof
Münch, Philipp
Danner, Sylvia
Dietzel, Anja
Krisam, Johannes
Klose, Christina
Pilz, Maximilian
Hoffmann, Jürgen
Freudlsperger, Christian
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (RI2813/3-1)
Ruprecht-Karls-Universität Heidelberg
Article History
Received: 18 April 2021
Accepted: 8 October 2021
First Online: 2 November 2021
Declarations
:
: Clinical Trial APOS Protocol (25-02-2021/Version 3) with the EudraCT No. 2020-001397-30 was approved by the designated lead research Ethics Board University of Heidelberg (AFmu-849/2020) and the German Federal Institute for Drugs and Medical Devices (BfArM). Written, informed consent to participate will be obtained from all participants.
: This manuscript does not contain individual personal data from patients.
: The authors declare that they have no competing interests.